8de Marinig F,Pereira JR,Fossella F,et al.Lung cancer symptom scale outcomes in relation to standard efficacy measures:an analysis of the phase Ⅲ study of pemetrexed versus docetaxel in advanced non-small cell lung cancer[J].J Thorac Oncol,2008,3:30-36.
9Tateishi U,Nishihara H,Tsukamoto E,et al.Lung rumors evaluated with FDG-PET and dynamic CT:the relationship between vascular density and glucose metabolism[J].J Comptu Assist Tumor,2002,26:185-190.
10Romaneehsen B,Anders M,Rohrl B,et al.Cryotherapy of malignant tumors:studies with MRI in an animal experiment and comparison with morphological changes[J].Rofo,2001,173:632-638.
3Waiters S, Maringe C, Butler J, et al. Comparability of stage data in cancer registries in six countries: lessons from the International Can- cer Benchrnarking Partnership [J]. lnt J Cancer, 2013, 132(3): 676-685.
4Alberg A J, Ford JG, Samet JM. E, pidemiology of lung cancer: AC- CP evidence-based clinical practice guidelines (2nd edition) [J]. Chest, 2007, 132(3 Suppl): 29-55.
5He WX, Hart BQ, Liu M, et al. Tmcheobronchial reconstructions with bronchoplastic closure: an alternative method in treatment of bronchogenic carcinoma involving the carina or tracheobronchial angle [J]. J Thorac Cardiovasc Surg, 2012, 144(2): 418-424.
6Okuma T, Matsuoka T, Yamamoto A, et al. Computed tomogra- play-guided re-radiofrequency ablation for unresectable lung tumor with local progression previously treated with the same procedure [J]. Radiat Med, 2008, 26(9): 519-525.
7Zhang J, Chen SF, Zhen Y, t al. Multicenter analysis of lung cancer patients younger than 45 years in Shanghai [J]. Cancer, 2010, 116 (15): 3656-3662.
